LYON, France, June 13 /PRNewswire/ -- - Sanofi pasteur Continues to Commit Resources and Join the International Community in Enhancing Pandemic Preparedness to Protect World Health Sanofi pasteur, the vaccines division of the sanofi-aventis Group, announced today that it is ready...
RIYADH, Saudi Arabia, March 4 /PRNewswire/ -- - Sanofi Pasteur Recognized as a key Contributor to Polio Eradication Efforts Sanofi pasteur (NYSE: SNY), the vaccines business of the sanofi-aventis Group, commends the Kingdom of Saudi Arabia for being declared a...
LYON, France, December 21 /PRNewswire/ -- Sanofi pasteur, the vaccines business of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), has entered into an agreement with BD (Becton, Dickinson and Company) (NYSE: BDX) to license the Micro-Deli LYON, France, December 21 /PRNewswire/...
Sanofi Pasteur Inc., Swiftwater, Pa., is being awarded a maximum $19,130,000 firm-fixed-price contract for the Influenza virus vaccine. The using services are Army, Navy, Air Force, and Marine Corps. There were 12 proposals solicited and 2 responded. This is an indefinite quantity type contract...
Acambis has landed a deal with Sanofi Pasteur, the vaccines arm of Sanofi-Aventis, for the promotion of its Japanese encephalitis JE vaccine. The two companies will co-promote the product - currently in Phase III trials - worldwide, but not in Ind Acambis has landed a...
HOUSTON -- Researched by Industrialinfo.com (Industrial Information Resources, Incorporated; Houston, Texas). Sanofi Pasteur's 275-acre Swiftwater, Pennsylvania, campus, the only location in the U.S. that manufactures injectable influenza vaccines, is growing once again.
www.AidsStocks.com, an investor and industry news portal for the Aids sector within the www.InvestorIdeas.com content portfolio, is pleased to announce that the industry analyst report, "Major Developments in the Treatment of HIV/Aids," by Griffin Securities is now available for review on the AidsStocks.com industry portal. Companies featured in the report...
M2 PRESSWIRE-21 July 2005-US Financial Network: Amgen Reaches 52 Week High on Strong Earnings and Sanofi-Pasteur SA Begins Work on Flu VaccinesC1994-2005 M2 COMMUNICATIONS LTD RDATE:21072005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU)....
NEEDHAM, Mass. -- AVANT Immunotherapeutics, Inc. (NASDAQ: AVAN) today announced that two leading executives from the vaccine industry have joined AVANT's Board of Directors. Alf A. Lindberg, M.D., Ph.D. was formerly Executive Vice President of R&D at Pasteur Merieux Connaught now sanofi pasteur and formerly Chief Scientific Officer and Head...
DEPARTMENT OF HEALTH AND HUMAN SERVICES has awarded sanofi pasteur, the vaccines business of the sanofi-aventis Group, a $100 million contract to manufacture avian influenza vaccine to protect against the H5N1 virus strain that has caused an avian flu epidemic in Asian (EPN, March 8, p....
MAKING VACCINES DIFFERENTLY. The Department of Health and Human Services has awarded a $97 million contract to Sanofi Pasteur in order to shift from making influenza vaccines by growing them in eggs to growing them in cell cultures. The latter proces MAKING VACCINES DIFFERENTLY. The Department...
M2 PRESSWIRE-10 March 2005-US Financial Network: NeoPharm President and Biogen Idec VP resignC1994-2005 M2 COMMUNICATIONS LTD RDATE:10032005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). Gregory Young has resigned as president and chief executive...
To deliver its range of vaccines for diseases like whooping cough, cholera, and polio as cost-effectively as possible, SanofiPasteur MSD, the UK-based specialist vaccines business of sanofi-aventis Group, needed to overcome its reliance on an outdated internal technology - its local, on-premises, pharmaceutical-industry CRM system. To increase sales effectiveness and...
M2 PRESSWIRE-30 March 2007-U.S. Equity News: MedImmune Licenses Reverse Genetics Technology and Amylin Could Make Major Investment in West ChesterC1994-2007 M2 COMMUNICATIONS LTD RDATE:30032007 City of Industry, CA - Biotechnology industry alert provided by U.S. Equity News. MedImmune, Inc. (Nasdaq: MEDI)...
Beat the crowds and save big on their favorite sports gear! Shop today
